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Abstract The potential role of protein kinase B (PKB), a ser-
ine/threonine protein kinase, in regulating HERG (human ether-
a-go-go related gene) K+ channel function was investigated.
Wortmannin (a phosphoinositide 3-kinase (PI3K) inhibitor)
caused V30% reduction of HERG current (IHERG) stably ex-
pressed in HEK293 cells. Transient transfection with the con-
stitutively active PI3K in HERG-expressing HEK293 cells
slightly increased (V7%) IHERG while a dominant negative
PI3K signi¢cantly reduced IHERG (V25%) relative to results
in vehicle-transfected cells. IHERG was V35% greater in cells
transfected with the constitutively activated PKB (caPKB),
whereas it was V47% smaller in cells transfected with domi-
nant negative PKB (dnPKB). Basal activation of PKB was de-
tected by immunocytochemistry. PKB activity was signi¢cantly
enhanced in caPKB-transfected cells and nearly abolished in
dnPKB-transfected cells. We conclude that normal HERG func-
tion in HEK293 cells requires basal activity of PKB. Our data
represent the ¢rst evidence that PKB phosphorylation regulates
K+ channels.
5 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Protein kinase B (PKB), a downstream target of phospho-
inositide 3-kinase (PI3K), is a serine/threonine (Ser/Thr) pro-
tein kinase ¢rst identi¢ed several years ago [1,2]. The cDNA
sequence of PKB displays high sequence homology to both
the protein kinase C and the protein kinase A family of Ser/
Thr kinases. It was therefore termed protein kinase B (PKB)
[1,2]. PKB can be activated by a wide variety of stimuli in a
PI3K-dependent or -independent manner [3,4]. The fungal
metabolite wortmannin (WMN) is a potent inhibitor of kinase
activities of class I PI3K, with an IC50 in the range of 1^10
nM [5]. By inhibiting PI3K, WMN can prevent PI3K-depen-
dent activation of PKB and it has been widely used to study
the physiological role of the PI3K/PKB signaling pathway in
various cellular processes.
It is well established that PKA and PKC can both regulate
ion channel function by Ser/Thr phosphorylation of channel
proteins, providing an important mechanism for regulation of
cell function. In contrast, the potential role of PKB in mod-
ulating ion channel function has been largely ignored. Only
recently has the PI3K/PKB pathway been found to be in-
volved in the regulation of some ion channels, for example,
the potentiation of L-type Ca2þ current and M-current in
neurons [6,7], enhancement of Cl3 currents in rat hepatoma
cells [8], and up-regulation of several Shaker-type Kþ chan-
nels in human embryonic kidney cell line [9]. It is believed that
modulation of these ion channels contributes to regulation by
PI3K/PKB of cell survival, cell growth, cell column and other
cell functions. Among these studies, however, only the work
reported by Blair et al. [6] demonstrated that the modulation
of the L-channel was PKB-dependent.
HERG (human ether-a-go-go related gene) encodes the rap-
id component of delayed recti¢er Kþ current in the heart, and
HERG dysfunction is known to account for both inherited
and acquired long Q-T syndrome [10], a potentially lethal
arrhythmia. Recent studies have revealed widespread distribu-
tion of HERG in various tissues and cells outside the heart,
including neurons [11,12], pancreatic L-cells [13], and a variety
of tumor cells [14,15], where in addition to its cardiac electro-
physiological role, HERG may also participate in the regula-
tion of cell growth and death [16]. The HERG protein con-
tains two putative consensus sequence motifs for PKB
phosphorylation located at S890 and S331 [4,17,18]. Although
HERG has been found to be a target for PKA phosphory-
lation [19^21] and probably also for PKC [22,23], it is un-
known whether it is also a substrate for PKB. The present
study was therefore undertaken to de¢ne the potential regu-
lation of HERG channel function by PKB.
2. Materials and methods
2.1. Cell culture
HEK293 cells stably expressing HERG (a kind gift from Drs. Z
Zhou and C. January) [24] were seeded in a 25 cm2 cell culture £ask
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and grown in Dulbecco’s modi¢ed Eagle’s medium (DMEM, Life
Technologies) supplemented with 10% heat-inactivated fetal bovine
serum, 200 Wg/ml G418 (Sigma), 100 U/ml penicillin and 100 Wg/ml
streptomycin (Life Technologies). The cells were subcultured to
V85% con£uence, harvested by trypsinization and stored in Tyrode’s
solution containing 0.5% bovine serum albumin (BSA) at 4‡C.
2.2. Gene transfection
The constructs expressing the constitutively active bovine PI3K
(caPI3K), pCMV6-p110K-mycC, and the dominant negative mouse
PI3K (dnPI3K) in pcDNA3, pcDNA3-vp110K-mycC, were kind gifts
from Dr. L. Cantley [25]. The constitutively active mouse PKB in
pECE (caPKB), and dominant negative bovine PKB in pCMV6
(dnPKB) were kind gifts from Dr. T. Franke and Dr. M. Greenberg
[25,26]. The cDNA transfection procedures have been described in
detail elsewhere [27]. Cells grown to V80% con£uence in 35 mm
culture dishes with DMEM free of antibiotics were washed once
with phosphate-bu¡ered saline. Aliquots containing 2^3 Wg of caP-
I3K, dnPI3K, caPKB, or dnPKB, plus 0.3 Wg pZX-CD8 plasmid
DNA were diluted into 100 Wl DMEM and mixed well with 6 Wl
Plus reagent from the LipofectAMINE Plus reagent kit (Life Tech-
nologies) and incubated at room temperature (RT) for 15 min. The
DNA-Plus reagent pre-complex was then added to 4 Wl LipofectAM-
INE reagent in 100 Wl of DMEM. The mixture was incubated at RT
for 15 min and added to the cells in a dish containing fresh serum-free
DMEM and swirled to distribute the complex uniformly, and incuba-
ted at 37‡C under 5% CO2 for 3 h. The cells were allowed to grow for
48 h before being harvested for analysis. Sham and blank control
experiments were conducted in parallel. For electrophysiological ex-
periments, the cells were harvested and incubated with 2 Wl anti-CD8
Dynabead (Dynal ASA, Oslo, Norway) at RT for 15 min to label the
transfected cells [27].
2.3. Whole-cell patch-clamp recording
Patch-clamp techniques have been described in detail elsewhere
[27,28]. Currents were recorded with whole-cell voltage-clamp with
an Axopatch-200B ampli¢er (Axon Instruments). Borosilicate glass
electrodes had tip resistances of 1^3 M6 when ¢lled with (mM):
130 KCl, 1 MgCl2, 5 Mg-ATP, 10 EGTA, 10 HEPES (pH 7.3).
The extracellular solution contained (mM): 136 NaCl, 5.4 KCl,
1 CaCl2, 1 MgCl2, 10 glucose and 10 HEPES (pH 7.4). Experiments
were conducted at 36S 1‡C. Junction potentials were zeroed before
formation of the membrane-pipette seal. Series resistance and capaci-
tance were compensated and leak currents were subtracted.
WMN (PI3K inhibitor; Sigma Chemicals), bisindolylmaleimide
(Bis; PKC inhibitor; Sigma Chemicals), and N-[2-(p-bromocinnamyl-
amino) ethyl]-5-isoquinolinesulfonamide-2HCl (H89; PKA inhibitor;
Biomol Research Labs, Plymouth Meeting, PA, USA) were dissolved
in dimethyl sulfoxide as 1000U stock solutions and stored at 320‡C,
and the stock solutions were diluted to the desired concentrations
right before the experiments.
2.4. Immunocytochemistry
The immunocytochemical procedures used have been previously
described in detail [16,29]. In short, cells grown on coverslips were
¢xed with freshly prepared 1% paraformaldehyde, followed by per-
meabilization in 0.1% Triton X-100 and blocked in 1% BSA. Cells
were then incubated overnight at 4‡C with primary antibodies diluted
in 1% BSA, followed by incubation with FITC- or TRITC-conjugated
secondary antibodies at room temperature for 2 h. Rabbit polyclonal
antibody against phospho-PKB (S473) was purchased from New Eng-
land BioLabs (Beverly, MA, USA) and goat polyclonal anti-CD8
antibody was purchased from Santa Cruz (Santa Cruz, CA, USA).
The speci¢city of the anti-phospho-PKB antibody has been tested in
our previous studies [30]. Donkey anti-rabbit, FITC-conjugated and
donkey anti-goat, TRITC-conjugated antibodies, purchased from
Jackson Immuno-Research (Baltimore, MD, USA), were used as sec-
ondary antibodies. Non-speci¢c staining by the secondary antibodies
was excluded by the absence of staining in cells treated with the sec-
ondary antibodies alone. Coverslips were mounted onto glass slides
with anti-fading mounting medium and were immediately examined
under confocal laser scanning microscope equipment (model LSM
510; Zeiss). Excitation/emission wavelengths for FITC and TRITC
were 488/512 and 543/576 nm, respectively and FITC (green) and
TRITC (red) were excited separately to avoid bleed-through e¡ects.
The settings for laser scanning and image, such as laser power, pin-
hole, ampli¢cation factor and gain, were set optimal to avoid false
positive or false negative stainings and for a given experiment, the
settings were identical for all slides under examination. Each image
represents an average from four consecutive slow-speed scannings.
Density of staining by anti-phospho-PKB antibody was measured
by the LSM 510 software suite and only positively stained cells
were analyzed except for the cells in control group.
2.5. Data analysis
Group data are expressed as meanSS.E.M. Paired or non-paired
Student’s t-tests were used for before-and-after or group comparisons
as appropriate. A two-tailed P6 0.05 was taken to indicate a statis-
tically signi¢cant di¡erence. Non-linear least-square curve-¢tting was
performed with CLAMPFIT in pCLAMP 8.0 or Graphpad Prism.
3. Results
3.1. E¡ects of WMN on HERG currents (IHERG)
Currents were recorded in HEK293 cells stably expressing
HERG with a two-step voltage protocol. The cell membrane
was held at 380 mV, and stepped from 360 mV to +40 mV
in 10 mV increments for 2.5 s to measure the step current and
then returned to a constant potential at 350 mV for 2.5 s to
measure the tail currents (Fig. 1A). The e¡ects of the inhibitor
of PI3K WMN were assessed following intracellular applica-
tion. WMN (50 nM) was included in the pipette solution and
dialyzed into the cytosol. Under our experimental conditions,
10 min was su⁄cient for complete dialysis. IHERG was re-
corded right after membrane rupture and the same measure-
ments were repeated every 5 min for a total of 20 min. The
recordings made 15 min after membrane rupture were used to
re£ect the e¡ects of WMN. As a control, cells were dialyzed
and currents recorded in an identical fashion, but with WMN
absent from the pipette solution. As illustrated in Fig. 1,
WMN appeared to have two e¡ects ^ a decrease in maximum
conductance, along with a voltage shift tending to increase
current at negative voltages. To ensure the suppression of
IHERG by WMN was not due to rundown of the current, we
compared IHERG recorded at various time points after mem-
brane rupture. The data in Fig. 1C show that in the absence
of WMN rundown of IHERG was minimum (V5%) whilst in
the presence of WMN IHERG demonstrated a profound at-
tenuation over a period of 15 min which coincided with the
time course of dialysis of internal solution through a pipette
under our experimental conditions. WMN did not alter the
kinetics (time-dependent activation, inactivation and reactiva-
tion) of the current (data not shown).
Additional experiments were performed to ensure that the
e¡ects of WMN on IHERG are not due to PKA and/or PKC
activation. Cells were ¢rst bathed with H89 (1 WM) to inhibit
PKA or Bis (100 nM) to inhibit PKC. Inhibitors were added
to Tyrode’s solution 20 min before patch-clamp recording
with WMN (50 nM)-containing pipettes. Under these condi-
tions, WMN produced qualitatively similar e¡ects to those
seen in experiments without H89 or Bis treatment. For exam-
ple, IHERG current density in the presence of H89 was 2.4S 0.6
pA/pF before and 3.4S 0.9 pA/pF (P6 0.05, n=6) after
WMN at 340 mV, and 51.7S 7.9 pA/pF before and
40.8S 7.3 pA/pF (P6 0.05) after WMN at 0 mV. In the pres-
ence of Bis, IHERG densities were 2.7 S 0.6 pA/pF before and
5.4S 1.3 pA/pF (P6 0.05, n=7) after WMN at 340 mV, and
63.9S 10.1 pA/pF before and 55.3 S 9.8 pA/pF (P6 0.05) after
WMN at 0 mV. To validate the concentrations of H89 and
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Bis used in our experiments, we conducted additional experi-
ments with Shaw-like voltage-gated Kþ channel Kv4.3 ex-
pressed in HEK293 cells and we found that 1 WM H89 and
100 nM Bis completely reversed the e¡ects produced by PKA
and PKC stimulation caused by isoproterenol and phenyleph-
rine, respectively (data not shown).
3.2. E¡ects of constitutively active or dominant negative PI3K
on IHERG
The results of the above experiments suggest that basal
PI3K/PKB activation contributes to maintaining IHERG/IKr
function in the absence of external stimuli for PI3K/PKB
activation. The data do not indicate whether the e¡ects are
due to PI3K activation, PKB activation or both. We began to
address this issue by transiently transfecting caPI3K into
HEK293 cells stably expressing HERG. IHERG recorded in
CD8 bead-labeled cells (indicating caPI3K transfection) was
compared with IHERG in untransfected cells or sham-treated
counterparts. The data are presented in Fig. 2, where greater
IHERG density was seen at potentials negative to 0 mV in
caPI3K-transfected cells relative to sham cells. For example,
IHERG density at 340 mV was 3.3S 0.4 pA/pF (n=30) for
Fig. 1. E¡ects of WMN on IHERG stably expressed in HEK293 cells. A: IHERG recordings made immediately after membrane rupture with min-
imal dialysis, taken as baseline control data (Ctl), and 15 min after membrane rupture with complete dialysis through the pipette containing
WMN (50 nM). IHERG was elicited with the voltage protocol shown in the inset. The same voltage protocol is applied to the subsequent ¢g-
ures. B: IHERG step current^voltage (I^V) relations. C: Changes of IHERG amplitude at 310 mV with time after formation of whole cell con¢g-
uration. Shown are data collected from recordings with pipettes without (Ctl, n=8) or with WMN (n=8). *P6 0.05 WMN vs. control.
Fig. 2. IHERG in cells transfected with caPI3K or dnPI3K. A: Typical examples of IHERG traces presented as current density (pA/pF) for better
group comparisons. For the sham group, the cells underwent the same transfection procedures as for dnPI3K and caPI3K groups, except that
the plasmids were not included. B,C: I^V relationships averaged from 30 cells for sham, 25 cells for dnPI3K, and 28 cells for caPI3K group.
*P6 0.05 vs. sham.
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sham control and 9.6 S 3.6 pA/pF (P6 0.05, n=25) for caP-
I3K (increased by V2-fold), and at 0 mV was 91.9S 9.5 pA/
pF for control and 102.4 S 11.4 pA/pF for caPI3K (increased
byV10%, Ps 0.05, unpaired t-test). At potentials positive to
310 mV, no appreciable di¡erences between groups were ob-
served. By contrast, the cells transfected with dnPI3K showed
increased IHERG only at potentials negative to 320 mV and
moderate reduction of IHERG was seen at potentials more
positive than 320 mV. For example, IHERG densities in
dnPI3K-transfected cells was 7.1S 2.6 pA/pF (V2-fold larger
than in the sham group, Ps 0.05) at 340 mV, and was
79.1S 11.7 pA/pF (V25% smaller than in the sham group,
Ps 0.05) at 0 mV. The e¡ects of dnPI3K are qualitatively
comparable to those of WMN.
3.3. E¡ects of constitutively active or dominant negative PKB
on IHERG
To test the potential direct role of PKB, we performed
experiments with transient transfection of caPKB or dnPKB
in HERG-expressing HEK293 cells. Consistent with an im-
portant role for PKB, caPKB increased and dnPKB decreased
IHERG. Fig. 3 compares IHERG in cells transfected with plas-
mids containing caPKB plus plasmids to cells with cDNAs
expressing CD8 alone, as well as untreated control cells. In
all cases, there were no signi¢cant di¡erences in IHERG be-
tween control and CD8-transfected cells. IHERG density mea-
sured from caPKB cells was clearly greater than that of con-
trol or CD8-transfected cells at all voltages ranging from 340
to +40 mV, and there was a tendency towards greater di¡er-
ences at more positive potentials. For example, IHERG density
was 36%, 37% and 67% greater at 340 mV, 0 mV and +40
mV, respectively, in caPKB than in control cells (Fig. 3C). On
the other hand, IHERG was substantially smaller in dnPKB-
transfected than in non-transfected or CD8-transfected cells at
potentials positive to 320 mV, but was greater at potentials
negative to this voltage (Fig. 3D^F). For instance, at 0 mV
Fig. 3. IHERG in HEK293 cells transfected with caPKB or dnPKB. A,D: Capacitance-normalized IHERG traces (pA/pF) for better group com-
parisons. The HEK293 cells with stable expression of HERG were transiently transfected with plasmids containing cDNAs expressing CD8
alone (CD8 group) or with additional cDNA plasmids encoding caPKB or dnPKB. B,E: Mean I^V relationships. For caPKB experiments,
n=19 cell for Ctl, = 16 for CD8 alone, and =23 for caPKB; for dnPKB experiments, n=20 cell for Ctl, = 19 for CD8 alone, and =19 for
dnPKB. C,F: Percent di¡erence of IHERG density between caPKB or dnPKB and Ctl groups. *P6 0.05 vs. control (Ctl).
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IHERG density values were 90.4 S 13.4 pA/pF (n=20 cells) and
48.7S 3.9 pA/pF (P6 0.05, n=19) in control and in dnPKB-
transfected cells, respectively, whereas at 340 mV, the IHERG
density was 11.8S 1.6 pA/pF for control and 19.3 S 5.0 pA/pF
(P6 0.05) for dnPKB cells. These data indicated a 46% de-
crease at 0 mV and a 53% increase at 340 mV in the presence
of dnPKB (Fig. 3F).
3.4. Immunocytochemical analysis of active PKB
To con¢rm that the e¡ects of WMN in our experiments are
associated with changes in PKB activity and that the cells
transfected with caPKB or dnPKB indeed have increased or
reduced PKB activity respectively, we performed immuno-
staining analyses of PKB activity using anti-phospho-PKB
(S473) antibody. For WMN experiments, cells were preincu-
bated with WMN (100 nM) in the culture medium for 30 min
before being collected for immunostaining. As shown in Fig.
4A, the immunoreactivity was obviously weaker in WMN-
treated than in control cells.
For caPKB/dnPKB experiments, double staining with anti-
PKB antibody and anti-CD8 antibody was performed to dis-
tinguish the transfected from the non-transfected cells. The
staining for phospho-PKB (green) was distributed in both
the membrane and the cytoplasm, and CD8, a membrane
protein co-transfected with caPKB as a marker for successful
transfection, was stained red only to the plasma membrane.
PKB staining was markedly more intense in cells also stained
with CD8 than in cells with negative CD8 staining (non-trans-
fected cells) in the same batch (Fig. 4B). The same was true
when compared with the control cells that did not undergo the
transfection procedures. In sharp contrast, the staining for
phospho-PKB was nearly absent although the staining for
CD8 was obvious in dnPKB-transfected cells.
The cells transfected with caPI3K showed a slightly higher
intensity, while the cells transfected with dnPI3K showed a
slightly lower intensity, of phospho-PKB staining than in their
respective non-transfected cells or the control cells (Fig. 4B).
The quantitative data are presented in Fig. 4C where the
ratios of staining intensity in positively stained cells over
non-stained control cells are shown.
4. Discussion
We demonstrated here that prevention of PI3K/PKB acti-
vation by pharmacological inhibition (WMN) or molecular
inactivation (dnPI3K and dnPKB) signi¢cantly suppressed
HERG function, whereas direct activation of PKB by intro-
ducing caPKB into the cell markedly enhanced HERG func-
tion. Inhibition of PKB activation by WMN or dnPI3K or
dnPKB and increased activation of PKB with caPKB trans-
fection were con¢rmed by immunocytochemistry with the use
of the anti-phospho-PKB antibody. Our data clearly indicate
that HERG Kþ channel function in HEK293 cells is enhanced
by PKB activation and also provide the evidence for the ¢rst
time that PKB phosphorylation participates in Kþ channel
modulation.
WMN, used to inhibit PI3K activation and thereby the
downstream PI3K-dependent PKB activation, produced re-
markable depression (V30% reduction) of IHERG stably ex-
pressed in HEK293 cells. The e¡ects were observed under
normal conditions in the absence of stimuli for PI3K/PKB
activation. Coincidentally, dnPI3K caused virtually the same
changes of IHERG as WMN did: V25% decrease in current
density and V5 mV shift of activation towards hyperpolariz-
ing potentials. By comparison, direct inactivation of PKB by
dnPKB produced a nearly doubled magnitude of e¡ects on
IHERG as produced by WMN; dnPKB diminished IHERG den-
sity by V53% and shifted the V1=2 by V6 mV. In addition,
while caPI3K produced only slight enhancement (V18%) of
IHERG function, caPKB strikingly increased IHERG density
(V52%). Correspondingly, caPI3K caused an only slight in-
crease in the active form of PKB whereas caPKB boosted
activation of PKB. Taken together these data allow us to
reach the following conclusions: (1) the PI3K/PKB signaling
pathway has regulatory e¡ects on HERG Kþ channel func-
tion because inhibition of the pathway diminishes but activa-
tion of the pathway enhances IHERG ; (2) PI3K/PKB modula-
tion of HERG is likely mediated by a direct e¡ect of PKB but
not PI3K phosphorylation because inhibition/activation of
PKB produced far more pronounced e¡ects on IHERG com-
pared with inhibition/activation of PI3K; (3) HERG is under
tonic regulation of basal active PKB, or in other words, basal
PKB activation is required for maintaining the normal phys-
iological function of the HERG Kþ channel in HEK293 cells,
because the e¡ects of PKB inhibition on IHERG, either by
pharmacological blockade (WMN) or by molecular inactiva-
tion (dnPI3K and dnPKB), were seen in the absence of stimuli
for PKB activation; and (4) the basal active PKB in HEK293
cells comes from both PI3K-dependent and PI3K-independent
mechanisms. The PI3K-dependent activation PKB is WMN-
sensitive, which can be prevented by treating the cells with
WMN, while the PI3K-independent activation of PKB is
WMN-insensitive. Introduction of dnPKB is expected to
wipe out both PI3K-dependent and PI3K-independent activa-
tion of PKB. Indeed, our present study consistently showed
that molecular inactivation of PKB by dnPKB produced some
doubled magnitudes of IHERG depression in comparison with
the e¡ects produced by WMN or dnPI3K. If the e¡ects of
WMN or dnPI3K on IHERG arise from the PI3K-dependent
activation of PKB, then the excess of e¡ects produced by
dnPKB over WMN or dnPI3K should represent PKB activa-
tion from PI3K-independent mechanisms.
The major ¢nding of this study is that PKB has a tonic
modulatory e¡ect on IHERG. Given the fact that dnPKB ren-
ders IHERG density half of its size under normal conditions, it
is expected that in the absence of basal PKB activation, IHERG
amplitude/density would be only 50% of its normal amplitude/
density. It is therefore reasonable to conclude that the basal
active PKB is required for maintaining the physiological func-
tion of IHERG in HEK293 cells. Moreover, our data from
caPKB experiments indicate that any further increase in
PKB activation may further increase IHERG beyond the basal
conditions. Increased PKB activity has actually been noticed
in a variety of physiological (such as growth stimulation, in-
creased adrenergic tone, etc.) and diseased conditions (such as
metabolic stress, oxidative challenge, ischemia, etc.) [3,4].
This ¢nding may have some important pathophysiological
implications. For example, it has long been known that the
cardiac action potential duration (APD) is initially shortened
in the early stage of acute myocardial ischemia and is subse-
quently prolonged in the late phase of ischemia, which is
associated with the occurrence of di¡erent types of arrhyth-
mias [31]. Coincidentally, PKB activities follow the same pat-
tern of changes: a marked increase in the early phase followed
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by an also marked drop in the late phase of ischemia [32].
Considering that the HERG-encoded Kþ current (the rapid
component of delayed recti¢er Kþ current or IKr) plays a
critical role in determining cardiac APD [10,33], we can spec-
ulate that in the early phase of ischemia the increase in PKB
activation enhances IKr which in turn accelerates the rate of
cardiac repolarization or shortens APD, whereas in the late
phase of ischemia when PKB activities are reduced IKr is
correspondingly diminished which then leads to lengthening
of APD. Also, cardiac APD was reported to be prolonged in
myocytes isolated from animals with type I diabetes and
slightly shortened in myocytes from type II diabetic animal
model [34^36]. It is unclear whether this is associated with a
decrease in PKB activation in type I diabetic subjects or an
increase in type II diabetes.
The PI3K signaling pathway is involved in diverse cellular
processes and some of these may be mediated by regulating
ion channels. A recent work by Gamper et al. [9] demon-
strated that insulin-like growth factor-1 (IGF-1) up-regulates
several voltage-gated Kþ channels belonging to the Shaker
subfamily including Kv1.1, Kv1.2 and Kv1.3 in HEK293 cells,
and the e¡ects were mediated by PI3K and its downstream
targets 3-phosphoinositide-dependent protein kinase 1 and se-
rum- and glucocorticoid-dependent kinase 1. Their data ex-
cluded the contribution of PKB to modulating Shaker Kþ
channels. Enhancement of Cl3 channel by PI3K that contrib-
utes to volume regulation in rat hepatoma cells was reported
by Feranchak et al. [8]. Using transient expression of wild-
type, dominant negative, and constitutively active forms of
PKB in cerebellar granule neurons, Blair et al. elegantly
showed that IGF-1 partially mediates granule neuron survival
via L-type Ca2þ channel activity and that PKB-dependent L-
channel modulation is a necessary component because PKB
mediates the IGF-1-induced potentiation of L-channel cur-
rents [6]. There have been no other previous studies on ion
channel modulation by PKB. Our data represent the ¢rst
evidence for the direct role of PKB in Kþ channel modula-
tion.
PKA, PKC and PKB are all Ser/Thr protein kinases, which
can phosphorylate their downstream e¡ectors and alter the
functional status of these downstream components. PKA
and PKC both have been shown to modulate Kþ channels
including HERG [19^23]. The minimum sequence motif re-
quired for optimal phosphorylation of peptide substrates by
PKB is RXRXXS/T*, where X is any amino acid, and * is
a bulky hydrophobic residue (phenylalanine or leucine) [3,4,
17,18]. The sequence requirement for PKB phosphorylation is
quite similar to that for PKC and distinct from that for PKA
[18]. There are three putative PKA phosphorylation sites and
one PKB favorite phosphorylation site (S890) in the C-termi-
nal region, as well as one site (S331) in the N-terminal region,
of the HERG sequence. Whether these sites are responsible
for HERG modulation by PKB merits further studies with
site-directed mutagenesis.
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